Clinical Trial Update: To Evaluate the Safety, Tolerability, Pharmacokinetics and Food Effects of IMM-H014 in Healthy Subjects [Phase 1]

View source ↗

Summary

Phase 1 clinical trial update evaluating safety, tolerability, pharmacokinetics, and food effects of IMM-H014 in healthy subjects, with a focus linked to nonalc…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Nonalcoholic Steatohepatitis

Drugs mentioned

• IMM-H014

Snippet

Sponsor: Changchun Intellicrown Pharmaceutical Co. LTD | Conditions: Nonalcoholic Steatohepatitis (NASH) | Phase 1 | Status: RECRUITING